Bausch & Lomb (BLCO)CEO bought ~$248K

~$248K

Approx. value · 22K sh @ $11.28

719K

Holds after · shares reported

Traded

May 22, 2025

Filed

May 27, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 2, 2025InsiderDirector purchased ~$20K of BLCO shares in the open market
2. May 22, 2025 · this disclosureInsiderCEO purchased ~$248K of BLCO shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bausch & Lomb

For Bausch & Lomb, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BLCO page.

Other recent filings by Brent L Saunders, CEO and Chairman of the Board

• SEC Form 4 at Ars Pharmaceuticals (SPRY)May 22, 2025

The full history of Brent L Saunders, CEO and Chairman of the Board is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Bausch & Lomb

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRAug 14, 2025
• SEC Form 13F-HRAug 14, 2025

Everything OQRO holds on this company is on its BLCO page.